Why NETCLASS NTCL Just Surged 419 Key Levels Ahead 20260515 Palvella Therapeutics Reports Positive Phase 2 Data for QTORIN Rapamycin in Cutaneous Venous Malformations Evercore EVR Slides 151 as Selling Pressure Mounts 20260515